Akso Health Group
AHG
$1.620 -2.99%
Exchange: NASDAQ | Sector: Financial Services | Industry: Financial Credit Services
Q4 2024
Published: Jul 30, 2024

Earnings Highlights

  • Revenue of $0.76M up 14.8% year-over-year
  • EPS of $-0.13 increased by 85.9% from previous year
  • Gross margin of 5.5%
  • Net income of -3.00M
  • "" -

Akso Health Group (AHG) QQ4 2024 Financial Results Analysis: Revenue Growth Amid Profitability Pressures and a Cash-Runded Balance Sheet

Executive Summary

AHG reported revenue of approximately $760.4 million for QQ4 2024, marking a YoY growth of 14.8% and QoQ growth of roughly 70%. Despite top-line momentum, the quarter delivered an operating loss of about $3.16 million and a net loss near $3.00 million, translating to a negative net margin of approximately 3.95%. The company’s conservative gross margin (5.48%) reflects the ongoing investment phase and mix of offerings, while significant non-operating items and expansion-related costs contributed to earnings shortfalls. Cash flow dynamics are favorable on a net basis: operating cash flow was modest at roughly $0.55 million, yet financing activities supplied a large inflow (about $65.65 million) supported by a substantial equity issuance (common stock issued around $140.07 million). The balance sheet shows a robust cash position (~$85.17 million) and a very high current ratio (~39.5x), underscoring liquidity strength but accompanied by a heavy deficit in retained earnings and continued negative earnings trajectory. Management commentary, where available, focused on platform growth and strategic investments; however, no formal quarterly guidance was disclosed in the provided data. Investors should weigh near-term profitability challenges against the potential for unit economics improvement and platform monetization as scale accelerates.

Key Performance Indicators

Revenue

760.38K
QoQ: 70.19% | YoY:14.82%

Gross Profit

41.65K
5.48% margin
QoQ: 114.53% | YoY:-41.79%

Operating Income

-3.16M
QoQ: -173.00% | YoY:54.99%

Net Income

-3.00M
QoQ: -95.85% | YoY:59.53%

EPS

-0.14
QoQ: 30.00% | YoY:85.86%

Revenue Trend

Margin Analysis

Key Insights

Revenue: $760.38m (YoY +14.8%, QoQ +70.2%); Gross Profit: $41.65m (Gross Margin 5.48%, YoY -41.8%, QoQ +114.5%); Operating Income: -$3.16m (Margin -4.16%, YoY +54.99%, QoQ -173.00%); Net Income: -$3.00m (Net Margin -3.95%, YoY +59.53%, QoQ -95.85%); EPS: -$0.14 (Diluted -$0.13; YoY +85.86%, QoQ +30%); Cash Flow: Operating cash flow $0.55m; Net cash from financing activities $65.65m; Net cash used in investing activities -$28.13m; Net change in cash $75.96m; Cash at end of period $85.17m; Balance...

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2024 0.76 -0.13 +14.8% View
Q3 2024 0.76 -0.13 +14.8% View
Q2 2024 0.45 -0.20 -92.5% View
Q1 2024 0.45 -0.20 -92.5% View
Q4 2023 0.66 -0.96 -92.5% View